Insider · CIK 0001433982
Jerome B Zeldis
Files at SNGX (SOLIGENIX, INC.), PTCT (PTC THERAPEUTICS, INC.), NXGL (NEXGEL, INC.). First filing Nov 22, 2024, latest Dec 4, 2024.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
PTCT: PTC THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
NXGL: NEXGEL, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | PTC THERAPEUTICS, INC. | $1.2M 24,000 shares | -91% | - | |
| 30Weak | NEXGEL, INC. | $9,999 3,636 shares | +4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | SNGX SOLIGENIX, INC. | AGrant or award Stock Option (Right to Buy)derivative | +78,947 | $0.00 | $0 | 78,947 | 24 d ago |
| Jun 25, 2025 | NXGL NEXGEL, INC. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 27, 2025 |
| Jun 20, 2025 | SNGX SOLIGENIX, INC. | AGrant or award Stock Option (Right to Buy)derivative | +17,647 | $0.00 | $0 | 17,647 | Jun 20, 2025 |
| Dec 12, 2024 | SNGX SOLIGENIX, INC. | AGrant or award Stock Option (Right to Buy)derivative | +8,646 | $0.00 | $0 | 8,646 | Dec 13, 2024 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +12,000 | $51.00 | $612k | 26,500 | Dec 4, 2024 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -8,813 | $51.44 | $453k | 17,687 | Dec 4, 2024 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -3,187 | $52.42 | $167k | 14,500 | Dec 4, 2024 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +12,000 | $30.86 | $370k | 26,500 | Dec 4, 2024 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -5,699 | $50.52 | $288k | 20,801 | Dec 4, 2024 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -2,634 | $51.43 | $135k | 18,167 | Dec 4, 2024 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -3,667 | $52.39 | $192k | 14,500 | Dec 4, 2024 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,000 | $0.00 | $0 | 0 | Dec 4, 2024 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,000 | $0.00 | $0 | 0 | Dec 4, 2024 |
| Nov 20, 2024 | NXGL NEXGEL, INC. | POpen-market purchase Common Stock | +3,636 | $2.75 | $9,999 | 106,664 | Nov 22, 2024 |
| Nov 20, 2024 | NXGL NEXGEL, INC. | AGrant or award Warrant to Purchase Common Stockderivative | +1,818 | $0.00 | $0 | 1,818 | Nov 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.